Researchers have identified RNA-based biomarkers that distinguish between normal, aging hematopoietic stem cells and leukemia stem cells associated with secondary acute myeloid leukemia (sAML), a particularly problematic disease that typically afflicts older patients who have often already experienced a bout with cancer.
About The Author
24 March, 2013
14 August, 2017
13 November, 2017
Our Facebook Page
Facebook By Weblizar Powered By Weblizar
amniotic stem cells Asterias Biology Biotech california stem cells Cancer CIRM CRISPR Daily Daily News fat stem cells fda FDA stem cells Health Image of the Day iPS cells Jeanne Loring Leigh Turner Masayo Takahashi Medical research Pharma Research review Sally Temple Science Society Startups stem cell clinic stem cell clinical trials stem cell clinics stem cell lawsuit Stem Cell News Stem Cell Person of the Year Stem Cell Research Stem cells Stem Cell Therapy stem cell treatment stem cell treatment cost Stemgenex SYN The Nutshell Top Story Uncategorized Viacyte World news